These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6255017)

  • 1. Hypothesis. Cyclic AMP and its receptor protein in tumor growth regulation in vivo.
    Cho-Chung YS
    J Cyclic Nucleotide Res; 1980; 6(3):163-77. PubMed ID: 6255017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
    Bodwin JS; Clair T; Cho-Chung YS
    Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic adenosine 3':5-monophosphate receptor proteins in hormone-dependent and -independent rat mammary tumors.
    Cho-Chung YS; Clair T; Schwimmer M; Steinberg L; Rego J; Grantham F
    Cancer Res; 1981 May; 41(5):1840-6. PubMed ID: 7214351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic AMP receptor triggers nuclear protein phosphorylation in a hormone-dependent mammary tumor cell-free system.
    Cho-Chung YS; Archibald D; Clair T
    Science; 1979 Sep; 205(4413):1390-2. PubMed ID: 224463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of hormone-dependent mammary tumors in Sprague-Dawley rats as a result of tamoxifen or pharmacologic doses of 17 beta-estradiol: cyclic adenosine 3',5'-monophosphate-mediated events.
    Bodwin JS; Hirayama PH; Rego JA; Cho-Chung YS
    J Natl Cancer Inst; 1981 Feb; 66(2):321-6. PubMed ID: 6256577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic AMP-binding protein and estrogen receptor: antagonism during nuclear translocation in a hormone-dependent mammary tumor.
    Bodwin JS; Hirayama PH; Cho-Chung YS
    Biochem Biophys Res Commun; 1981 Dec; 103(4):1349-55. PubMed ID: 6277332
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclic AMP-dependent protein kinase type I and type II and cyclic AMP binding in human mammary tumors.
    Eppenberger U; Biedermann K; Handschin JC; Fabbro D; Küng W; Huber PR; Roos W
    Adv Cyclic Nucleotide Res; 1980; 12():123-8. PubMed ID: 6250347
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclic adenosine 3':5'-monophosphate and protein kinase activity in insulin-dependent and -independent mammary tumors.
    Shafie SM; Cho-Chung YS; Gullino PM
    Cancer Res; 1979 Jul; 39(7 Pt 1):2501-4. PubMed ID: 221106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic AMP and mammary tumor regression.
    Cho-Chung YS
    Cell Mol Biol Incl Cyto Enzymol; 1980; 26(4):395-403. PubMed ID: 6254654
    [No Abstract]   [Full Text] [Related]  

  • 10. Antagonistic action between cyclic adenosine 3':5'-monophosphate and estrogen in rat mammary tumor growth control.
    Cho-Chung YS
    Cancer Res; 1978 Nov; 38(11 Pt 2):4071-5. PubMed ID: 212186
    [No Abstract]   [Full Text] [Related]  

  • 11. Nucleolar accumulation of cyclic adenosine 3':5'-monophosphate receptor proteins during regression of MCF-7 human breast tumor.
    Kapoor CL; Grantham F; Cho-Chung YS
    Cancer Res; 1984 Aug; 44(8):3554-60. PubMed ID: 6331652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic adenosine 3':5'-monophosphate-dependent protein phosphorylation and the control of leukemia L1210 cell growth.
    Mednieks MI; Jungmann RA; DeWys WD
    Cancer Res; 1982 Jul; 42(7):2742-7. PubMed ID: 6282449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent changes in growth-related biochemical parameters during regression of hormone-dependent rat mammary tumors.
    Foecking MK; Abou-Issa H; Webb TE; Minton JP
    J Natl Cancer Inst; 1983 Oct; 71(4):773-8. PubMed ID: 6312151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biochemical mechanisms of the stimulating action of estradiol on the growth of mammary tumours.
    Morozova TM; Mitina RL; Nagibneva IN; Ozhogina ZB; Salganik RI
    Exp Clin Endocrinol; 1986 Dec; 88(3):293-302. PubMed ID: 3030784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP receptor protein and cyclic AMP-dependent protein kinase activity in rabbit peritoneal neutrophils.
    Huang CK; Mackin WM; Bormann BJ; Becker EL
    J Reticuloendothel Soc; 1983 Nov; 34(5):413-21. PubMed ID: 6644693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the mechanism of cyclic AMP-mediated growth arrest of solid tumors.
    Cho-Chung YS
    Adv Cyclic Nucleotide Res; 1980; 12():111-21. PubMed ID: 6250346
    [No Abstract]   [Full Text] [Related]  

  • 17. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
    Nesterova MV; Cho-Chung YS
    Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies on cyclic AMP binding and protein kinase in cyclic AMP-responsive and -unresponsive Walker 256 mammary carcinomas.
    Cho-Chung YS; Clair T; Yi PN; Parkison C
    J Biol Chem; 1977 Sep; 252(18):6335-41. PubMed ID: 19471
    [No Abstract]   [Full Text] [Related]  

  • 19. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
    Cho YS; Kim MK; Tan L; Srivastava R; Agrawal S; Cho-Chung YS
    Clin Cancer Res; 2002 Feb; 8(2):607-14. PubMed ID: 11839683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of nuclear cyclic AMP binding in cyclic AMP-unresponsive Walker 256 mammary carcinoma.
    Cho-Chung YS; Clair T; Huffman P
    J Biol Chem; 1977 Sep; 252(18):6349-55. PubMed ID: 197089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.